I'm Passing on Pfizer Stock in 2024. Here's Why.

One of the most important companies during the peak of the COVID-19 pandemic was pharmaceutical giant Pfizer (PFE 1.06%). The company's breakthrough vaccine helped pave the way for a post-pandemic world. Over the last couple of years, demand for Pfizer's COVID-19 treatments helped spur record-breaking revenue.However, as pandemic concerns wane, some investors may wonder where Pfizer's next growth engine lies. While the company has several catalysts identified, I have my doubts on their prospects. And I'm no ...